364 related articles for article (PubMed ID: 10967078)
1. VEGF is major stimulator in model of choroidal neovascularization.
Kwak N; Okamoto N; Wood JM; Campochiaro PA
Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):3158-64. PubMed ID: 10967078
[TBL] [Abstract][Full Text] [Related]
2. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration.
Wood JM; Bold G; Buchdunger E; Cozens R; Ferrari S; Frei J; Hofmann F; Mestan J; Mett H; O'Reilly T; Persohn E; Rösel J; Schnell C; Stover D; Theuer A; Towbin H; Wenger F; Woods-Cook K; Menrad A; Siemeister G; Schirner M; Thierauch KH; Schneider MR; Drevs J; Martiny-Baron G; Totzke F
Cancer Res; 2000 Apr; 60(8):2178-89. PubMed ID: 10786682
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of vascular endothelial growth factor (VEGF) as a novel approach for cancer therapy.
Wood JM
Medicina (B Aires); 2000; 60 Suppl 2():41-7. PubMed ID: 11188930
[TBL] [Abstract][Full Text] [Related]
4. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
Yano S; Herbst RS; Shinohara H; Knighton B; Bucana CD; Killion JJ; Wood J; Fidler IJ
Clin Cancer Res; 2000 Mar; 6(3):957-65. PubMed ID: 10741721
[TBL] [Abstract][Full Text] [Related]
5. Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization.
Ozaki H; Seo MS; Ozaki K; Yamada H; Yamada E; Okamoto N; Hofmann F; Wood JM; Campochiaro PA
Am J Pathol; 2000 Feb; 156(2):697-707. PubMed ID: 10666398
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro.
Tille JC; Wood J; Mandriota SJ; Schnell C; Ferrari S; Mestan J; Zhu Z; Witte L; Pepper MS
J Pharmacol Exp Ther; 2001 Dec; 299(3):1073-85. PubMed ID: 11714897
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of protein kinase C decreases prostaglandin-induced breakdown of the blood-retinal barrier.
Saishin Y; Saishin Y; Takahashi K; Melia M; Vinores SA; Campochiaro PA
J Cell Physiol; 2003 May; 195(2):210-9. PubMed ID: 12652648
[TBL] [Abstract][Full Text] [Related]
8. Suppression of choroidal neovascularization by inhibiting angiotensin-converting enzyme: minimal role of bradykinin.
Nagai N; Oike Y; Izumi-Nagai K; Koto T; Satofuka S; Shinoda H; Noda K; Ozawa Y; Inoue M; Tsubota K; Ishida S
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2321-6. PubMed ID: 17460297
[TBL] [Abstract][Full Text] [Related]
9. Complete inhibition of vascular endothelial growth factor (VEGF) activities with a bifunctional diabody directed against both VEGF kinase receptors, fms-like tyrosine kinase receptor and kinase insert domain-containing receptor.
Lu D; Jimenez X; Zhang H; Wu Y; Bohlen P; Witte L; Zhu Z
Cancer Res; 2001 Oct; 61(19):7002-8. PubMed ID: 11585724
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of VEGF secretion and experimental choroidal neovascularization by picropodophyllin (PPP), an inhibitor of the insulin-like growth factor-1 receptor.
Economou MA; Wu J; Vasilcanu D; Rosengren L; All-Ericsson C; van der Ploeg I; Menu E; Girnita L; Axelson M; Larsson O; Seregard S; Kvanta A
Invest Ophthalmol Vis Sci; 2008 Jun; 49(6):2620-6. PubMed ID: 18515591
[TBL] [Abstract][Full Text] [Related]
11. Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor.
Smith LE; Shen W; Perruzzi C; Soker S; Kinose F; Xu X; Robinson G; Driver S; Bischoff J; Zhang B; Schaeffer JM; Senger DR
Nat Med; 1999 Dec; 5(12):1390-5. PubMed ID: 10581081
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta induces expression of vascular endothelial growth factor in human retinal pigment epithelial cells: involvement of mitogen-activated protein kinases.
Nagineni CN; Samuel W; Nagineni S; Pardhasaradhi K; Wiggert B; Detrick B; Hooks JJ
J Cell Physiol; 2003 Dec; 197(3):453-62. PubMed ID: 14566975
[TBL] [Abstract][Full Text] [Related]
13. The adapter protein, Grb10, is a positive regulator of vascular endothelial growth factor signaling.
Giorgetti-Peraldi S; Murdaca J; Mas JC; Van Obberghen E
Oncogene; 2001 Jul; 20(30):3959-68. PubMed ID: 11494124
[TBL] [Abstract][Full Text] [Related]
14. Design of GFB-111, a platelet-derived growth factor binding molecule with antiangiogenic and anticancer activity against human tumors in mice.
Blaskovich MA; Lin Q; Delarue FL; Sun J; Park HS; Coppola D; Hamilton AD; Sebti SM
Nat Biotechnol; 2000 Oct; 18(10):1065-70. PubMed ID: 11017044
[TBL] [Abstract][Full Text] [Related]
15. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
Timke C; Zieher H; Roth A; Hauser K; Lipson KE; Weber KJ; Debus J; Abdollahi A; Huber PE
Clin Cancer Res; 2008 Apr; 14(7):2210-9. PubMed ID: 18381963
[TBL] [Abstract][Full Text] [Related]
16. Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model.
Reich SJ; Fosnot J; Kuroki A; Tang W; Yang X; Maguire AM; Bennett J; Tolentino MJ
Mol Vis; 2003 May; 9():210-6. PubMed ID: 12789138
[TBL] [Abstract][Full Text] [Related]
17. Selective inhibition of vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) activity by a monoclonal anti-VEGF antibody blocks tumor growth in mice.
Brekken RA; Overholser JP; Stastny VA; Waltenberger J; Minna JD; Thorpe PE
Cancer Res; 2000 Sep; 60(18):5117-24. PubMed ID: 11016638
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor- and platelet-derived growth factor-angiogenesis depressed but fetal bovine serum-angiogenesis enhanced choroidal tissue cultures of streptozotocin-diabetic Wistar and GK rats.
Kimura I; Yanagita S; Kobayshi S; Fukuta M; Okabe M
Int Angiol; 2000 Mar; 19(1):26-34. PubMed ID: 10853682
[TBL] [Abstract][Full Text] [Related]
19. VEGF-induced activation of phosphoinositide 3-kinase is dependent on focal adhesion kinase.
Qi JH; Claesson-Welsh L
Exp Cell Res; 2001 Feb; 263(1):173-82. PubMed ID: 11161716
[TBL] [Abstract][Full Text] [Related]
20. Effect of VEGF receptor inhibitor PTK787/ZK222584 [correction of ZK222548] combined with ionizing radiation on endothelial cells and tumour growth.
Hess C; Vuong V; Hegyi I; Riesterer O; Wood J; Fabbro D; Glanzmann C; Bodis S; Pruschy M
Br J Cancer; 2001 Dec; 85(12):2010-6. PubMed ID: 11747347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
